GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Cyclically Adjusted Price-to-FCF

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Cyclically Adjusted Price-to-FCF : 63.34 (As of May. 26, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Price-to-FCF?

As of today (2024-05-26), Shanghai Pharmaceuticals Holding Co's current share price is ¥18.37. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.29. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF for today is 63.34.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:601607' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 23.62   Med: 52.16   Max: 92.46
Current: 63.84

During the past years, Shanghai Pharmaceuticals Holding Co's highest Cyclically Adjusted Price-to-FCF was 92.46. The lowest was 23.62. And the median was 52.16.

SHSE:601607's Cyclically Adjusted Price-to-FCF is ranked worse than
90.63% of 32 companies
in the Medical Distribution industry
Industry Median: 26.27 vs SHSE:601607: 63.84

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥-1.728. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.29 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Price-to-FCF Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.04 49.21 55.18 48.61 39.35

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.89 59.98 48.62 39.35 59.13

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF falls into.



Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=18.37/0.29
=63.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Shanghai Pharmaceuticals Holding Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.728/115.2271*115.2271
=-1.728

Current CPI (Mar. 2024) = 115.2271.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.228 98.200 0.268
201409 0.082 98.900 0.096
201412 -0.017 99.000 -0.020
201503 -0.203 99.900 -0.234
201506 0.126 99.500 0.146
201509 -0.064 100.500 -0.073
201512 0.003 100.600 0.003
201603 -0.022 102.200 -0.025
201606 0.040 101.400 0.045
201609 -0.021 102.400 -0.024
201612 -0.062 102.600 -0.070
201703 -0.014 103.200 -0.016
201706 0.122 103.100 0.136
201709 0.041 104.100 0.045
201712 0.090 104.500 0.099
201803 -0.130 105.300 -0.142
201806 0.187 104.900 0.205
201809 0.087 106.600 0.094
201812 0.272 106.500 0.294
201903 -0.092 107.700 -0.098
201906 0.483 107.700 0.517
201909 0.038 109.800 0.040
201912 0.711 111.200 0.737
202003 -0.476 112.300 -0.488
202006 1.157 110.400 1.208
202009 0.344 111.700 0.355
202012 0.303 111.500 0.313
202103 -0.596 112.662 -0.610
202106 0.954 111.769 0.984
202109 0.043 112.215 0.044
202112 -0.070 113.108 -0.071
202203 -1.080 114.335 -1.088
202206 0.403 114.558 0.405
202209 -0.156 115.339 -0.156
202212 1.044 115.116 1.045
202303 -0.896 115.116 -0.897
202306 0.945 114.558 0.951
202309 -0.032 115.339 -0.032
202312 0.603 114.781 0.605
202403 -1.728 115.227 -1.728

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Pharmaceuticals Holding Co  (SHSE:601607) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Ren Jian senior management
Liu Yan Jun senior management
Hu Feng Xiang Director
Zuo Min Director
Guo Jun Yu senior management
Han Min senior management
Lou Ding Bo Director
Chen Xin Supervisors
Shu Chang senior management
Li Yong Zhong senior management
Jiang Yuan Ying senior management
Xu Guo Xiong Director
Shen Bo senior management
Ge Jian Qiu senior management

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines